CN105054065B - A kind of antioxidant composition and its application, health food - Google Patents
A kind of antioxidant composition and its application, health food Download PDFInfo
- Publication number
- CN105054065B CN105054065B CN201510510865.7A CN201510510865A CN105054065B CN 105054065 B CN105054065 B CN 105054065B CN 201510510865 A CN201510510865 A CN 201510510865A CN 105054065 B CN105054065 B CN 105054065B
- Authority
- CN
- China
- Prior art keywords
- vitamin
- composition
- enriched yeast
- health food
- muskmelon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 235000013402 health food Nutrition 0.000 title claims abstract description 16
- 230000003078 antioxidant effect Effects 0.000 title abstract description 25
- 239000003963 antioxidant agent Substances 0.000 title abstract description 23
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 80
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 39
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 39
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 39
- 239000011709 vitamin E Substances 0.000 claims abstract description 39
- 229940046009 vitamin E Drugs 0.000 claims abstract description 39
- 235000009847 Cucumis melo var cantalupensis Nutrition 0.000 claims abstract description 31
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 30
- 239000000284 extract Substances 0.000 claims abstract description 27
- 230000003064 anti-oxidating effect Effects 0.000 claims abstract description 9
- 244000241257 Cucumis melo Species 0.000 claims abstract 5
- 230000002829 reductive effect Effects 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 5
- 235000013373 food additive Nutrition 0.000 claims description 4
- 239000002778 food additive Substances 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 3
- 235000006708 antioxidants Nutrition 0.000 abstract description 21
- 235000013305 food Nutrition 0.000 abstract description 8
- 230000036541 health Effects 0.000 abstract description 8
- 230000002195 synergetic effect Effects 0.000 abstract description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 44
- 239000011669 selenium Substances 0.000 description 32
- 244000064895 Cucumis melo subsp melo Species 0.000 description 27
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 25
- 229960003180 glutathione Drugs 0.000 description 22
- 102000019197 Superoxide Dismutase Human genes 0.000 description 19
- 108010012715 Superoxide dismutase Proteins 0.000 description 19
- 238000012360 testing method Methods 0.000 description 18
- 150000003254 radicals Chemical class 0.000 description 13
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 11
- 229910052711 selenium Inorganic materials 0.000 description 11
- 229940091258 selenium supplement Drugs 0.000 description 11
- 230000000694 effects Effects 0.000 description 9
- -1 oxygen radical Chemical class 0.000 description 9
- 239000000463 material Substances 0.000 description 8
- 230000032683 aging Effects 0.000 description 7
- 230000003647 oxidation Effects 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 108010024636 Glutathione Proteins 0.000 description 6
- 238000010171 animal model Methods 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 235000013376 functional food Nutrition 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 241000219095 Vitis Species 0.000 description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 description 3
- 235000012333 Vitis X labruscana Nutrition 0.000 description 3
- 235000014787 Vitis vinifera Nutrition 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000007884 disintegrant Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000035558 fertility Effects 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 235000010384 tocopherol Nutrition 0.000 description 3
- 229960001295 tocopherol Drugs 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 238000005502 peroxidation Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 230000024883 vasodilation Effects 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- QGKMIGUHVLGJBR-UHFFFAOYSA-M (4z)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinoline;iodide Chemical group [I-].C12=CC=CC=C2N(CCC(C)C)C=CC1=CC1=CC=[N+](CCC(C)C)C2=CC=CC=C12 QGKMIGUHVLGJBR-UHFFFAOYSA-M 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000244203 Caenorhabditis elegans Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000239183 Filaria Species 0.000 description 1
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000000950 Hippophae rhamnoides Species 0.000 description 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 1
- 208000019926 Keshan disease Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 235000016357 Mirtillo rosso Nutrition 0.000 description 1
- 206010057178 Osteoarthropathies Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039921 Selenium deficiency Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- LUSZGTFNYDARNI-UHFFFAOYSA-N Sesamol Natural products OC1=CC=C2OCOC2=C1 LUSZGTFNYDARNI-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 244000077923 Vaccinium vitis idaea Species 0.000 description 1
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 241001593968 Vitis palmata Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- FRYDSOYOHWGSMD-UHFFFAOYSA-N [C].O Chemical class [C].O FRYDSOYOHWGSMD-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000003026 anti-oxygenic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 231100000012 chronic liver injury Toxicity 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 210000001630 jejunum Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000004783 oxidative metabolism Effects 0.000 description 1
- 150000002927 oxygen compounds Chemical class 0.000 description 1
- 208000024691 pancreas disease Diseases 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000010204 pine bark Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920006389 polyphenyl polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 230000019100 sperm motility Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 125000002640 tocopherol group Chemical group 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The present invention relates to technical field of health care food, more particularly to a kind of antioxidant composition and its application, health food.Said composition includes muskmelon extract, vitamin E and Se-enriched yeast.After the present invention is by the way that muskmelon extract, vitamin E and Se-enriched yeast are used cooperatively, in the case where greatly reducing each component dosage, composition provided by the invention is remarkably improved SOD vigor and GSH contents, generates obvious synergistic function, has significant anti-oxidation efficacy.
Description
Technical field
The present invention relates to technical field of health care food, more particularly to a kind of antioxidant composition and its application, health food.
Background technology
Aging be biology over time, spontaneous necessary process, it is complicated natural phenomena, shows as structure
And hypofunction, adaptability and resistance decline.People why can one of gradual aging, its reason be body carry out it is a series of
While oxidative metabolism, free radical is constantly be generated, superfluous free radical may act on the lipid materials such as blood, cell, tissue,
It is set to become MDA, these peroxide are deposited on cell membrane, are made cell membrane loss of function, are caused cell viability
Decline, tissue organ function's decline, body enters aging state.These oxides are also deposited on vascular wall, cause blood vessel hard
Change, easily produce angiorrhoxis.Superfluous free radical can also act on intracellular hereditary material DNA, make cell carcinogenesis or dead
Die.
The antioxidation of body can keep the generation of free radical and the balance eliminated, have to prevention disease and anti-ageing wait for a long time
Significance.Anti-oxidant mean to oxidation resistant effect, makes cell from the damage of free radical, or is referred to as resistance human body because of oxygen
Compound matter is that oxygen radical causes the aging chronic disease such as cardiovascular and cerebrovascular diseases, diabetes, tumour, osteoarthropathy, senile dementia
Mechanism, so as to play anti-oxidant, anti-aging effects.
Although body has various polyphenoils to carry out the blocking to free radical, when this blocking is insufficient
(during such as illness, aging), the balance between the generation and elimination of free radical will be lost, and oxidative damage will occur.In order to add
Strong anti-preheater system, promote oxidation resistance, it is necessary to from supplementing the various materials with oxidation resistance in vitro, including various resist
Food and medicine, the i.e. defence of free radical and seizure property polyphenoils are aoxidized, with the ecological balance of environment in maintenance.Ordinary people is every
It is averagely taken in 1200~1500 unit ORAC (Oxygen Radical Absorbance Capacity) and refers to oxygen radical suction
Receipts ability, that is, test the general international standard unit of food and medicine moderate resistance oxide content.ORAC content is higher, suppresses freely
The oxidation resistance of base is stronger.But expert points out, balanced for protective intracellular metabolite, 5000~6000 must be taken in for each person every day
Unit ORAC.And inferior health and the elderly population amount of daily intaking then necessarily be greater than 10000 unit ORAC, normal generation could be maintained
Thank to balance, effectively drive away internal free radical, resist aging and various aging diseases.Therefore, human body must be mended additionally daily
Fill polyphenoils.The exogenous antioxidant being currently known mainly has:
Vitamin E:Also known as tocopherol, it is primarily present in cell mitochondrial film and endoplasmic reticulum, phenolic hydroxyl group can be by vivaciously
H atom freer base, become stable fertility quinone.One vitamin E can remove 2 free radicals, and vitamin E is anti-with ROO
Vitamin E free radical should be generated.Vitamin E can remove single line O2, and can removes alkane free radical and MDA is free
Base.It is directly acted on the cell membrane of human body, there is superpower oxidation resistance, specially catches oxygen radical, protects cell
Lipid on film is not oxidized, and cholesterol of giving a piece of bad advice can not adhere on vascular wall, keep the clean conditions of blood.
Vitamin C:Vitamin C, which removes, can remove free radical (such as O2, OH) outside, can also make fertility quinone recover vitamin E prototype,
Continue play remove free radical effect, as long as therefore have enough vitamin Cs, so that it may make the vitamin E of low concentration continue to play
Effect.Vitamin C is synthesized by glucose (G1u), because the mankind lack ester oxidase in Glu, so can not directly synthesize.Dimension
Raw plain C mainly absorbs in jejunum, and healthy human blood's content is 48.3~79.5umol/L.
Grape amine:That is cyanine oligomer (oligomeric proanthocyanidins complexes, OPC),
It is present in pine bark, peanut skin, grape pip, cowberry, lemon bark, dried orange peel and seabuckthorn seeds.It is 1986 big by French ripple Dorr
Learn Maas professor Kai Lier to find, be the most strong free radical scavenger found so far.The plant containing OPC has in the world
Kind more than 4000, and OPC (grape phenol) effect extracted from red grape pip is most obvious, its oxidation resistance is ascorbic 20
Again, 50 times of vitamin E.For correcting inferior health, make it that there is positive role to health conversion.
In addition, exogenous antioxidant is also red including beta carotene, polyphenyl phenol, children's phenol, isoflavones element, Lycopene, shrimp
Element, sesamol etc..
During different polyphenoils compounding uses, its antioxidant effect may be better than a kind of independent antioxygen of antioxidant
Change effect because during two or more polyphenoils compounding use, various antioxidants after anti-oxidant,
Caused free radical, which can interact, generates new phenolic compound, continues to play antioxidation, obtains its antioxygenic property
With enhancing.Therefore it provides a kind of composite antioxidant that can significantly increase antioxidant effect is significant.
The content of the invention
In view of this, the invention provides a kind of antioxidant composition and its application, health food.The present invention is by by perfume (or spice)
After melon extract, vitamin E and Se-enriched yeast are used cooperatively, in the case where greatly reducing each component dosage, the present invention provides
Composition be remarkably improved SOD vigor and GSH contents, generate obvious synergistic function, have significant anti-oxidant
Effect.
In order to realize foregoing invention purpose, the present invention provides following technical scheme:
The invention provides a kind of composition, including muskmelon extract, vitamin E and Se-enriched yeast.
Muskmelon, also known as muskmelon, property are sweet, cold, nontoxic;Muskmelon pedicel is bitter, cold, poisonous.Enter stomach, lung, large intestine.Containing a large amount of carbon hydrates
Thing and citric acid etc., and moisture is abundant, can relieve summer heat heat-clearing, quench one's thirst of promoting the production of body fluid, relieving restlessness;Invertase in muskmelon can be by insoluble protein
Qualitative change can help kidney patient to absorb nutrition into soluble protein;Vitamin B in the muskmelon base of a fruit can protect liver, mitigate
Chronic liver injury;Modern study finds that sunflower seed kills the effect such as roundworm, filaria;It is nutritious, needed by human body can be supplemented
Energy and nutrient.
Vitamin E (Vitamin E) is a kind of liposoluble vitamin, and its hydrolysate is tocopherol, is most important anti-
One of oxidant.It is dissolved in the organic solvents such as fat and ethanol, it is not soluble in water, it is stable to heat, acid, it is unstable to alkali, it is quick to oxygen
Sense, to heat it is insensitive, but it is fried when Vitamin E activity substantially reduce.Vitamin E has protection T lymphocytes, protection red thin
Born of the same parents, Green Tea Extract oxidation, the effect for suppressing platelet aggregation, so as to reduce the danger of myocardial infarction and cerebral infarction.Also to burning
Wound, frostbite, capillary hemorrhage, climacteric metancholia, beauty etc. have the effect of fine.It has also been found that vitamin E can suppress
Lipid peroxidation reaction in ocular lens body, make peripheral vasodilation, improve blood circulation.In addition, tocopherol can promotion property swash
Element secretion, make man's sperm motility and quantity increase;Increase woman's female hormone concentration, improve fecundity, prevention of miscarriage.
Recently it has also been found that vitamin E can suppress the lipid peroxidation reaction in ocular lens body, make peripheral vasodilation, improve blood and follow
Ring, pre- Anti-myopic eye occurrence and development.
Trace element necessary to selenium is human body, there is critically important physiological function, healthy closely related with the mankind.Selenium energy
Enough prevention and suppression tumours, anti-aging, the normal function for maintaining cardiovascular system, prevention of arterial hardening and the appearance of coronary heart disease.
Selenium deficiency can cause Keshan disease and big bone knot disease, can also induce cataract, hepatopathy and Pancreas Disease etc..Se-enriched yeast is in culture ferment
Add selenium element in female process, absorbed selenium during yeast growth, made selenium and the protein and polysaccharide organic in yeast
With reference to Biological Selenium is converted into, the toxicity and stomach of human body are stimulated so as to eliminate chemical selenium (such as sodium selenite), make selenium
Can more efficient, be more safely absorbed by the body utilization.Se-enriched yeast is also most efficient, most safe, nutrition domestic so far
Most balanced selenium-replenishing preparation.
After the present invention is by the way that muskmelon extract, vitamin E and Se-enriched yeast are used cooperatively, used greatly reducing each component
In the case of amount, composition provided by the invention is remarkably improved SOD vigor and GSH contents, generates obvious Synergistic
Effect.
In some embodiments provided by the invention, muskmelon extract can be commercially available prod, also can voluntarily be made.
In some embodiments provided by the invention, active constituent content >=1IU/mg in muskmelon extract.
Preferably, vitamin E is natural VE, i.e. d- alpha-tocopherols acetate.
In some embodiments provided by the invention, the active constituent content of vitamin E is >=50%.
In some embodiments provided by the invention, Se-enriched yeast is cereuisiae fermentum rich in selenoaminoacid.
In some embodiments provided by the invention, the content of selenium is 1000~1300ppm in cereuisiae fermentum rich in selenoaminoacid.
Preferably, the mass ratio of muskmelon extract, vitamin E and Se-enriched yeast is (1~10):(0.1~3):(0.3
~2).
In some embodiments provided by the invention, the mass ratio of muskmelon extract, vitamin E and Se-enriched yeast is 1:
0.1:0.3。
In other embodiments provided by the invention, the mass ratio of muskmelon extract, vitamin E and Se-enriched yeast is 5:
1.5:1。
In other embodiments provided by the invention, the mass ratio of muskmelon extract, vitamin E and Se-enriched yeast is
10:3:2。
Present invention also offers application of the said composition in anti-oxidation efficacy health food or medicine is prepared;Said composition
Including muskmelon extract, vitamin E and Se-enriched yeast;Preferably, the quality of muskmelon extract, vitamin E and Se-enriched yeast
Than for (1~10):(0.1~3):(0.3~2);In some embodiments provided by the invention, muskmelon extract, vitamin E with
The mass ratio of Se-enriched yeast is 1:0.1:0.3;In other embodiments provided by the invention, muskmelon extract, vitamin E with
The mass ratio of Se-enriched yeast is 5:1.5:1;In other embodiments provided by the invention, muskmelon extract, vitamin E and richness
The mass ratio of selenium yeast is 10:3:2.
In some embodiments provided by the invention, anti-oxidation efficacy includes:MDA (MDA) content is reduced, is improved super
Superoxide dismutase (SOD) vigor, or improve glutathione (GSH) content.
Present invention also offers a kind of health food, including the present composition;Said composition includes muskmelon extract, dimension
Raw plain E and Se-enriched yeast;Preferably, the mass ratio of muskmelon extract, vitamin E and Se-enriched yeast is (1~10):(0.1~
3):(0.3~2);In some embodiments provided by the invention, the mass ratio of muskmelon extract, vitamin E and Se-enriched yeast is
1:0.1:0.3;In other embodiments provided by the invention, the mass ratio of muskmelon extract, vitamin E and Se-enriched yeast is
5:1.5:1;In other embodiments provided by the invention, the mass ratio of muskmelon extract, vitamin E and Se-enriched yeast is
10:3:2。
In some embodiments provided by the invention, in addition to food additives.
In some embodiments provided by the invention, the formulation of health food is tablet, pulvis or capsule.But the present invention
This is not limited to, those skilled in the art think feasible formulation within protection scope of the present invention.
Preferably, food additives are selected from disintegrant, lubricant or adhesive in health caring food tablet.But the present invention is simultaneously
It is non-limiting in this, those skilled in the art think feasible food additives within protection scope of the present invention.
In some embodiments provided by the invention, disintegrant is carboxyrnethyl starch sodium or PVPP.But the present invention is simultaneously
It is non-limiting in this, those skilled in the art think feasible disintegrant within protection scope of the present invention.
In some embodiments provided by the invention, lubricant is silica, magnesium stearate.It is but of the invention and non-limiting
In this, those skilled in the art think feasible lubricant within protection scope of the present invention.
In some embodiments provided by the invention, adhesive is PVP, carboxycellulose sodium or syrup.But the present invention
This is not limited to, those skilled in the art think feasible adhesive within protection scope of the present invention.
Present invention also offers the preparation method of the health caring food tablet:Supplementary material is mixed, pelletized, tabletting, coating.
The invention provides a kind of antioxidant composition and its application, health food.Said composition include muskmelon extract,
Vitamin E and Se-enriched yeast.After the present invention is by the way that muskmelon extract, vitamin E and Se-enriched yeast are used cooperatively, subtracting significantly
In the case of few each component dosage, composition provided by the invention is remarkably improved SOD vigor and GSH contents, generates obvious
Synergistic function, there is significant anti-oxidation efficacy.
Embodiment
The invention discloses a kind of antioxidant composition and its application, health food, those skilled in the art can use for reference
Present disclosure, it is suitably modified technological parameter realization.In particular, all similar replacements and change are to this area skill
It is it will be apparent that they are considered as being included in the present invention for art personnel.The present invention method and application by compared with
Good embodiment is described, related personnel substantially can not depart from present invention, in spirit and scope to as described herein
Methods and applications are modified or suitably changed with combining, to realize and using the technology of the present invention.
Raw materials used or auxiliary material can be purchased by market in antioxidant composition provided by the invention and its application, health food
.Wherein, muskmelon extract supplier is French ISOCELL companies;Natural VE supplier is U.S. ADM;Selenium-enriched beer
Yeast supplier is Angel Yeast Co., Ltd.
With reference to embodiment, the present invention is expanded on further:
The anti-oxidation function of embodiment 1 is tested
1st, experiment material
1.1 key instruments and reagent
Animal platform balance, thermostat water bath, spectrophotometer, ultraviolet specrophotometer, low-temperature and high-speed centrifuge, suspension device
Deng.MDA (MDA), protein carbonyl group, superoxide dismutase (SOD) and reductive glutathione (GSH) testing cassete are by green cloud
Its bio tech ltd provides.
1.2 experimental animal
From SPF levels Kunming kind Healthy female mouse, 6-8 week old, body weight 18-22g, by Guangdong Province medical experiment animal
Center provides.
1.3 dosage regimen
After animal is quarantined three days in laboratory conditions, seven groups are randomly divided into, every group 12, daily gavage tested material, is given
Medicine composition and dosage are shown in Table 1, are increased and decreased to sample amount according to body weight weekly and adjusted, and experimental period is 30 days, and contact gavage is prohibited after 30 days
Food 16 hours, adopts tail point hematometry MDA (MDA) content, whole blood polyphenoils reductive glutathione (GSH) content;Pluck
Eyeball blood sampling centrifugation is taken, takes serum to determine antioxidant enzyme superoxide mutase (SOD) vigor.Remarks:Mouse is administered according to people
10 times of body recommended amounts.
Composition and dosage is administered in table 1
2nd, result of the test
Influence of 2.1 samples to experimental animal Liver MDA
Influence of each group sample of table 2 to experimental animal Liver MDA
1-5 groups are tested compared with Normal group, last MDA contents is tested and has all declined compared with Normal group, wherein
First and secondth, four, six test groups are compared with Normal group significantly (P<0.05), the 5th test group is compared with Normal group significantly (P<
0.01)。
Influence (be shown in Table 3) of 2.2 samples to experimental animal liver superoxide dismutase (SOD) vigor.
Influence of the sample of table 3 to experimental animal liver superoxide dismutase (SOD) vigor
1-5 groups are tested with respect to Normal group, last SOD vigor (U/mL) is tested and is all increased compared with Normal group, its
In the five, the six test groups compared with Normal group extremely significantly (P<0.01), the 4th test group is compared with Normal group significantly (P<0.05),
First, second and third test group all increases compared with Normal group, but without significant relation (P > 0.05).
Influence (be shown in Table 4) of 2.3 samples to experimental animal serum reductive glutathione GSH contents.
Influence of each group of table 4 to aged mouse whole blood reductive glutathione GSH contents
1-5 groups are tested with respect to Normal group, the 4th, the 5th group of experiment end GSH content (μ g/ μ L) is compared with Normal group all
Increase and significantly (P < 0.05), the 6th test group GSH contents significantly improve (P < 0.01) compared with Normal group pole, other
Control and control group GSH contents all increase, but without significant relation (P > 0.05).
From above-mentioned result of the test:
In terms of composition is to the influence of superoxide dismutase (SOD) vigor, after each component dosage is greatly reduced, the
Four test group SOD vigor are compared with Normal group significant difference (P < 0.05);6th test group SOD vigor is poor compared with Normal group
Different notable (P < 0.01);And the first test group to the 3rd test group SOD vigor (P > not notable compared with Normal group difference
0.05).It can be seen that composition provided by the invention is remarkably improved SOD vigor after each material is used in combination, generate bright
Aobvious synergistic function.
In terms of composition is to the influence of reductive glutathione GSH contents, after each component dosage is greatly reduced, the 4th
Test group GSH contents are compared with Normal group significant difference (P < 0.05);6th test group GSH contents are compared with Normal group difference
Significantly (P < 0.01);And the first test group to the 3rd test group GSH contents is not notable (P > 0.05) compared with Normal group difference.
It can be seen that composition provided by the invention is remarkably improved GSH contents after each material is used in combination, obvious collaboration is generated
Synergistic effect.
The preparation of the antioxidant functional food of embodiment 2
The formula of antioxidant functional food capsule is as shown in table 5.
The formula (1000) of the antioxidant functional food capsule of table 5
The preparation technology of health-care edible capsule agent is as follows:
The supplementary material of formula ratio is weighed, it is standby;Each supplementary material is put into mixer and mixed 20~30 minutes.
Above-mentioned compound is packed into capsule using Autocapsulefillingmachine, loading amount is 0.4g/ grains.
The preparation of the antioxidant functional food of embodiment 3
The formula of antioxidant functional food tablet is as shown in table 6.
The formula of the antioxidant functional food tablet of table 6
The preparation technology of health caring food tablet is as follows:
Each supplementary material is weighed, tabletting is made 1000 according to a conventional method for mixing, every 600mg.
Described above is only the preferred embodiment of the present invention, it is noted that for the ordinary skill people of the art
For member, under the premise without departing from the principles of the invention, some improvements and modifications can also be made, these improvements and modifications also should
It is considered as protection scope of the present invention.
Claims (6)
1. a kind of composition, it is characterised in that be made up of muskmelon extract, vitamin E and Se-enriched yeast;
The mass ratio of muskmelon extract, vitamin E and Se-enriched yeast is 1:0.1:0.3;
Or the mass ratio of muskmelon extract, vitamin E and Se-enriched yeast is 5:1.5:1.
2. application of the composition as claimed in claim 1 in anti-oxidation efficacy health food or medicine is prepared.
3. application according to claim 2, it is characterised in that the anti-oxidation efficacy includes:MDA contents are reduced, are improved
SOD vigor, or improve GSH contents.
4. a kind of health food, it is characterised in that including composition as claimed in claim 1.
5. health food according to claim 4, it is characterised in that also including food additives.
6. health food according to claim 4, it is characterised in that the formulation of the health food be tablet, pulvis or
Capsule.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510510865.7A CN105054065B (en) | 2015-08-19 | 2015-08-19 | A kind of antioxidant composition and its application, health food |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510510865.7A CN105054065B (en) | 2015-08-19 | 2015-08-19 | A kind of antioxidant composition and its application, health food |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105054065A CN105054065A (en) | 2015-11-18 |
CN105054065B true CN105054065B (en) | 2018-02-09 |
Family
ID=54483788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510510865.7A Active CN105054065B (en) | 2015-08-19 | 2015-08-19 | A kind of antioxidant composition and its application, health food |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105054065B (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100435812C (en) * | 2005-12-29 | 2008-11-26 | 颜怀伟 | Compound antioxidation nutritive food and its manufacturing method |
CN101569414B (en) * | 2008-04-29 | 2013-04-10 | 安琪酵母股份有限公司 | Composition containing rich yeast selenium and yeast glucan |
CN101611862A (en) * | 2008-06-26 | 2009-12-30 | 威海清华紫光科技开发有限公司 | The preparation of water soluble pearl powder and method for producing soft capsule |
CN104605365A (en) * | 2013-11-05 | 2015-05-13 | 张俊霆 | Anti-ageing capsule |
-
2015
- 2015-08-19 CN CN201510510865.7A patent/CN105054065B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN105054065A (en) | 2015-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Berry et al. | The Middle Eastern and biblical origins of the Mediterranean diet | |
US6326031B1 (en) | Method of decreasing cholesterol and triglycerides levels with a composition containing fish oil, garlic, rutin, and capsaicin | |
US20090110674A1 (en) | Health supplement | |
JP5638180B2 (en) | Foods containing Salacia plant extracts and flavonoids | |
KR102299934B1 (en) | Composition for preventing or treating liver damage by alcohol which is excellent in hangover resolution | |
CN101306074B (en) | Anti-alcohol and liver- protection medicine composition | |
CN104983791A (en) | Health-care product containing coenzyme Q10 and preparation method thereof | |
JP2018058903A (en) | Growth hormone secretion promoter | |
CN103431392B (en) | Composite marine food for special dietary uses for diabetics | |
CN110101088A (en) | Accurate nutritional meal replacement composition and its application method for gestational diabetes mellitus prevention and treatment | |
CN104055180A (en) | High-selenium-and-germanium enzyme beverage | |
CN112156143B (en) | Compound nutrient composition with antioxidant function | |
KR101419194B1 (en) | Composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of elderly | |
RU2283124C1 (en) | Biologically active preparation based on marine vegetable raw | |
CN105054065B (en) | A kind of antioxidant composition and its application, health food | |
De Leiris et al. | Diet and heart health: moderate wine drinking strengthens the cardioprotective effects of fish consumption | |
KR102172316B1 (en) | A composition comprising rose flower extract for reducing body fat and a health functional food comprising the composition | |
TW201709920A (en) | Composition of Maqui berry plus multi fruits and berries for increasing body anti-oxidation capacity | |
US11090274B2 (en) | Formulation and method for supporting retinal health thereby reducing the risk of age-related macular degeneration (AMD) | |
CN102613576A (en) | Breast health and beauty nutritional tablets | |
US20100297268A1 (en) | Agent for increasing blood adiponectin quantity | |
AU6282796A (en) | Fish oil and garlic nutritive composition | |
Jung et al. | Antioxidant activities of different parts of Synurus deltoids Nakai extracts in vitro | |
KR20200046957A (en) | Health functional food composition comprising organic cale as main component | |
CN104543817A (en) | Blueberry seed powder as well as preparation method and application of blueberry seed powder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |